NCT03817385

Brief Summary

Patients with stroke have demonstrated abnormal muscle tone and postural control ability which affect their ambulation, activity of daily living and confident. Nowadays, utilizing repetitive transcranial magnetic stimulation (rTMS) and robotic machines to assist walking training for stroke patients has been applied to clinic widely. While less studies have compared intervention efficacy for stroke patients between rTMS and robotic training. This study aimed to compare effect of rTMS and robotic training for lower-extremity function and gait in stroke patients.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
105

participants targeted

Target at P75+ for not_applicable stroke

Timeline
Completed

Started Feb 2019

Typical duration for not_applicable stroke

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 28, 2018

Completed
28 days until next milestone

First Posted

Study publicly available on registry

January 25, 2019

Completed
7 days until next milestone

Study Start

First participant enrolled

February 1, 2019

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2021

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2022

Completed
Last Updated

July 1, 2021

Status Verified

June 1, 2021

Enrollment Period

2.8 years

First QC Date

December 28, 2018

Last Update Submit

June 30, 2021

Conditions

Keywords

Transcranial magnetic stimulationRobotic gait trainingGaitSpasticity

Outcome Measures

Primary Outcomes (14)

  • Change of walking speed

    walk 6m to measure the time spent, patients can walk with foot orthosis and assistive devices

    baseline: before intervention, 1st examination: finish the intervention(repetitiveTMS:10 times treatments(2weeks);robotic GT:20 times treatments (4weeks)), 2nd examination: 7 weeks after intervention

  • Change of postural sway displacement

    Use computerized dynography to measure the postural sway displacement (mm)

    baseline: before intervention, 1st examination: finish the intervention(repetitiveTMS:10 times treatments(2weeks);robotic GT:20 times treatments (4weeks)), 2nd examination: 7 weeks after intervention

  • Change of postural sway velocity

    Use computerized dynography to measure the postural sway velocity (mm/s)

    baseline: before intervention, 1st examination: finish the intervention(repetitiveTMS:10 times treatments(2weeks);robotic GT:20 times treatments (4weeks)), 2nd examination: 7 weeks after intervention

  • Change of postural sway area

    computerized dynography to measure the postural sway area (mm\^2)

    baseline: before intervention, 1st examination: finish the intervention(repetitiveTMS:10 times treatments(2weeks);robotic GT:20 times treatments (4weeks)), 2nd examination: 7 weeks after intervention

  • Change of step time

    Use computerized dynography to measure spatial gait parameter: step time (ms)

    baseline: before intervention, 1st examination: finish the intervention(repetitiveTMS:10 times treatments(2weeks);robotic GT:20 times treatments (4weeks)), 2nd examination: 7 weeks after intervention

  • Change of stance time

    Use computerized dynography to measure spatial gait parameter: stance time (ms)

    baseline: before intervention, 1st examination: finish the intervention(repetitiveTMS:10 times treatments(2weeks);robotic GT:20 times treatments (4weeks)), 2nd examination: 7 weeks after intervention

  • Change of swing time

    Use computerized dynography to measure spatial gait parameter: swing time (ms)

    baseline: before intervention, 1st examination: finish the intervention(repetitiveTMS:10 times treatments(2weeks);robotic GT:20 times treatments (4weeks)), 2nd examination: 7 weeks after intervention

  • Change of single support time

    Use computerized dynography to measure spatial gait parameter: single support time (ms)

    baseline: before intervention, 1st examination: finish the intervention(repetitiveTMS:10 times treatments(2weeks);robotic GT:20 times treatments (4weeks)), 2nd examination: 7 weeks after intervention

  • Change of double support time

    Use computerized dynography to measure spatial gait parameter: double support time (ms)

    baseline: before intervention, 1st examination: finish the intervention(repetitiveTMS:10 times treatments(2weeks);robotic GT:20 times treatments (4weeks)), 2nd examination: 7 weeks after intervention

  • Change of step length

    Use computerized dynography to measure spatial gait parameter: step distance (mm)

    baseline: before intervention, 1st examination: finish the intervention(repetitiveTMS:10 times treatments(2weeks);robotic GT:20 times treatments (4weeks)), 2nd examination: 7 weeks after intervention

  • Change of stance length

    Use computerized dynography to measure spatial gait parameter: stance distance (mm)

    baseline: before intervention, 1st examination: finish the intervention(repetitiveTMS:10 times treatments(2weeks);robotic GT:20 times treatments (4weeks)), 2nd examination: 7 weeks after intervention

  • Change of amplitude of Muscle activity

    use electromyography to measure the muscles activity in microvolts (uv) included quadriceps, hamstrings, tibialis anterior, gastrocnemius during subject walking in self selected speed in 6 meters.

    baseline: before intervention, 1st examination: finish the intervention(repetitiveTMS:10 times treatments(2weeks);robotic GT:20 times treatments (4weeks)), 2nd examination: 7 weeks after intervention

  • Change of Functional Independence Measure (FIM)

    FIM™ is comprised of 18 items, grouped into 2 subscales - motor and cognition. The motor subscale includes: Eating Grooming Bathing Dressing, upper body Dressing, lower body Toileting Bladder management Bowel management Transfers - bed/chair/wheelchair Transfers - toilet Transfers - bath/shower Walk/wheelchair Stairs The cognition subscale includes: Comprehension Expression Social interaction Problem solving Memory Each item is scored on a 7 point ordinal scale, ranging from a score of 1 to a score of 7. The higher the score, the more independent the patient is in performing the task associated with that item. The total score for the FIM motor subscale will be a value between 13 and 91. The total score for the FIM cognition subscale will be a value between 5 and 35. The total score for the FIM instrument will be a value between 18 and 126.

    baseline: before intervention, 1st examination: finish the intervention(repetitiveTMS:10 times treatments(2weeks);robotic GT:20 times treatments (4weeks)), 2nd examination: 7 weeks after intervention

  • Change of international Quality of Life Assessment Short Form -36 (SF-36)

    including 8 health concepts: (1) physical functioning, (2) role limitations because of physical health problems; (3) bodily pain, (4) social functioning, (5) general mental health (psychological distress and psychological wellbeing), (6) role limitations because of emotional problems, (7) vitality (energy/fatigue), (8) general health perceptions. Scoring: answers to each question are scored which are then summed and transformed to a 0 - 100 scale.

    baseline: before intervention, 1st examination: finish the intervention(repetitiveTMS:10 times treatments(2weeks);robotic GT:20 times treatments (4weeks)), 2nd examination: 7 weeks after intervention

Secondary Outcomes (11)

  • Change of concentration of Serum albumin

    baseline: before intervention, 1st examination: finish the intervention(repetitiveTMS:10 times treatments(2weeks);robotic GT:20 times treatments (4weeks)), 2nd examination: 7 weeks after intervention

  • Change of concentration of Hemoglobin (Hb)

    baseline: before intervention, 1st examination: finish the intervention(repetitiveTMS:10 times treatments(2weeks);robotic GT:20 times treatments (4weeks)), 2nd examination: 7 weeks after intervention

  • Change of concentration of Glucose

    baseline: before intervention, 1st examination: finish the intervention(repetitiveTMS:10 times treatments(2weeks);robotic GT:20 times treatments (4weeks)), 2nd examination: 7 weeks after intervention

  • Change of concentration of Cholesterol

    baseline: before intervention, 1st examination: finish the intervention(repetitiveTMS:10 times treatments(2weeks);robotic GT:20 times treatments (4weeks)), 2nd examination: 7 weeks after intervention

  • Change of concentration of Triglyceride

    baseline: before intervention, 1st examination: finish the intervention(repetitiveTMS:10 times treatments(2weeks);robotic GT:20 times treatments (4weeks)), 2nd examination: 7 weeks after intervention

  • +6 more secondary outcomes

Study Arms (3)

repetitive TMS (Transcranial Magnetic Stimulation)

EXPERIMENTAL

rTMS and physical / occupational therapy

Device: repetitive TMS

robotic GT (Gait Training)

EXPERIMENTAL

robotic gait training for 20 times and physical / occupational therapy

Device: robotic GT

traditional rehabilitation

NO INTERVENTION

patient only received traditional rehabilitation program

Interventions

rTMS x 10 times

repetitive TMS (Transcranial Magnetic Stimulation)

robotic gait training for 20 times

robotic GT (Gait Training)

Eligibility Criteria

Age20 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • first-time onset of stroke
  • reaching 20 years old and having clinical CT and MRI diagnosis of stroke
  • hemiparesis with sitting ability after onset 3 months

You may not qualify if:

  • Brunnstrom stage over grade V
  • Combined other neurological diseases (epilepsy, polyneuropathy, Meniere's disease, vestibular neuritis, Parkinson's disease, dementia, spinocerebellar ataxia)
  • lower extremity disease, included joint contracture, high muscle tone(MAS more than 3), L/E fracture, Joint replacement, long-term osteoarthritis pain
  • unstable vital sign
  • can't coordinate or Sign consent plan form

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Changhua Christian Hospital

Changhua, 500, Taiwan

RECRUITING

Related Publications (12)

  • Brunt D, Greenberg B, Wankadia S, Trimble MA, Shechtman O. The effect of foot placement on sit to stand in healthy young subjects and patients with hemiplegia. Arch Phys Med Rehabil. 2002 Jul;83(7):924-9. doi: 10.1053/apmr.2002.3324.

    PMID: 12098151BACKGROUND
  • Dettmann MA, Linder MT, Sepic SB. Relationships among walking performance, postural stability, and functional assessments of the hemiplegic patient. Am J Phys Med. 1987 Apr;66(2):77-90.

    PMID: 3578493BACKGROUND
  • Hidler J, Nichols D, Pelliccio M, Brady K. Advances in the understanding and treatment of stroke impairment using robotic devices. Top Stroke Rehabil. 2005 Spring;12(2):22-35. doi: 10.1310/RYT5-62N4-CTVX-8JTE.

    PMID: 15940582BACKGROUND
  • Kakuda W, Abo M, Watanabe S, Momosaki R, Hashimoto G, Nakayama Y, Kiyama A, Yoshida H. High-frequency rTMS applied over bilateral leg motor areas combined with mobility training for gait disturbance after stroke: a preliminary study. Brain Inj. 2013;27(9):1080-6. doi: 10.3109/02699052.2013.794973.

    PMID: 23834634BACKGROUND
  • Kim J, Park JH, Yim J. Effects of respiratory muscle and endurance training using an individualized training device on the pulmonary function and exercise capacity in stroke patients. Med Sci Monit. 2014 Dec 5;20:2543-9. doi: 10.12659/MSM.891112.

    PMID: 25488849BACKGROUND
  • Hornby TG, Campbell DD, Kahn JH, Demott T, Moore JL, Roth HR. Enhanced gait-related improvements after therapist- versus robotic-assisted locomotor training in subjects with chronic stroke: a randomized controlled study. Stroke. 2008 Jun;39(6):1786-92. doi: 10.1161/STROKEAHA.107.504779. Epub 2008 May 8.

    PMID: 18467648BACKGROUND
  • Israel JF, Campbell DD, Kahn JH, Hornby TG. Metabolic costs and muscle activity patterns during robotic- and therapist-assisted treadmill walking in individuals with incomplete spinal cord injury. Phys Ther. 2006 Nov;86(11):1466-78. doi: 10.2522/ptj.20050266.

    PMID: 17079746BACKGROUND
  • Kim P, Warren S, Madill H, Hadley M. Quality of life of stroke survivors. Qual Life Res. 1999 Jun;8(4):293-301. doi: 10.1023/a:1008927431300.

    PMID: 10472161BACKGROUND
  • Macko RF, Ivey FM, Forrester LW, Hanley D, Sorkin JD, Katzel LI, Silver KH, Goldberg AP. Treadmill exercise rehabilitation improves ambulatory function and cardiovascular fitness in patients with chronic stroke: a randomized, controlled trial. Stroke. 2005 Oct;36(10):2206-11. doi: 10.1161/01.STR.0000181076.91805.89. Epub 2005 Sep 8.

    PMID: 16151035BACKGROUND
  • Ng SS, Hui-Chan CW. The timed up & go test: its reliability and association with lower-limb impairments and locomotor capacities in people with chronic stroke. Arch Phys Med Rehabil. 2005 Aug;86(8):1641-7. doi: 10.1016/j.apmr.2005.01.011.

    PMID: 16084820BACKGROUND
  • Nichols DS. Balance retraining after stroke using force platform biofeedback. Phys Ther. 1997 May;77(5):553-8. doi: 10.1093/ptj/77.5.553.

    PMID: 9149764BACKGROUND
  • Wang RY, Tseng HY, Liao KK, Wang CJ, Lai KL, Yang YR. rTMS combined with task-oriented training to improve symmetry of interhemispheric corticomotor excitability and gait performance after stroke: a randomized trial. Neurorehabil Neural Repair. 2012 Mar-Apr;26(3):222-30. doi: 10.1177/1545968311423265. Epub 2011 Oct 5.

    PMID: 21974983BACKGROUND

MeSH Terms

Conditions

StrokeMuscle Spasticity

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesMuscular DiseasesMusculoskeletal DiseasesMuscle HypertoniaNeuromuscular ManifestationsNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Ta-Sen Wei, Doctor

    Changhua Christian Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director, Physical Medical and Rehabilitation, Principal Investigator, Clinical Professor

Study Record Dates

First Submitted

December 28, 2018

First Posted

January 25, 2019

Study Start

February 1, 2019

Primary Completion

December 1, 2021

Study Completion

January 1, 2022

Last Updated

July 1, 2021

Record last verified: 2021-06

Data Sharing

IPD Sharing
Will not share

only for research

Locations